Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

penpulimab

(pen-PUH-lih-mab)

A drug used alone or with other drugs to treat certain types of nasopharyngeal cancer (a type of head and neck cancer). It is used in adults whose cancer cells do not form masses of cells that contain keratin. It is also being studied in the treatment of other types of cancer. Penpulimab binds to a protein called PD-1, which is found on T cells (a type of immune cell). Penpulimab may block PD-1 and help the immune system kill cancer cells. It is a type of monoclonal antibody and a type of immune checkpoint inhibitor.

penpulimab

Search NCI's Dictionary of Cancer Terms